Medicament comprising inhibitors of long pentraxin PTX3

Details for Australian Patent Application No. 2004305341 (hide)

Owner Defiante Farmaceutica LDA.

Inventors Garlanda, Cecilia; Carminati, Paolo; Mantovani, Alberto; Bottazzi, Barbara

Agent Davies Collison Cave

Pub. Number AU-A-2004305341

PCT Pub. Number WO2005/060997

Priority RM2003A000596 23.12.03 IT

Filing date 21 December 2004

Wipo publication date 7 July 2005

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

Event Publications

29 June 2006 PCT application entered the National Phase

  PCT publication WO2005/060997 Priority application(s): WO2005/060997

16 October 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004305342-Medicament comprising PTX3, alone or in combination with TSG-6, for treating degenerative diseases of cartilage and bone and treating female infertility

2004305337-Use of IL-6 in the preparation of pharmaceutical compositions for treating and preventing liver injury